Outset Medical, Inc. (OM) Financial Statements (2026 and earlier)

Company Profile

Business Address 3052 ORCHARD DRIVE
SAN JOSE, CA 95134
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:168,946158,685203,324287,500339,500314,900
Cash and cash equivalent35,006124,01468,50973,222182,348294,972
Short-term investments133,94034,671134,815214,280157,14019,898
Other undisclosed cash, cash equivalents, and short-term investments    (2)1230
Receivables28,32935,61932,98028,07025,6006,468
Inventory, net of allowances, customer advances and progress billings47,60959,38749,21551,47639,18518,384
Inventory47,60959,38749,21551,47639,18518,384
Other undisclosed current assets5,9994,5305,7006,5995,5176,159
Total current assets:250,883258,221291,219373,645409,802345,911
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization      
Operating lease, right-of-use asset4,7973,9405,3756,1177,2318,253
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization4,6708,13313,27315,87612,96414,998
Restricted cash and investments3,8293,3293,3293,31133,31133,311
Other noncurrent assets3172,1726051,1661561,356
Total noncurrent assets:13,61317,57422,58226,47053,66257,918
TOTAL ASSETS:264,496275,795313,801400,115463,464403,829
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities15,62225,43831,79728,36734,80526,893
Employee-related liabilities✕✕✕✕✕24,94816,845
Accounts payable5543,8625,8276031,7634,948
Accrued liabilities15,06821,57625,97027,7648,0945,100
Deferred revenue13,79512,75311,7278,6626,3403,201
Debt   4,7502,0252,025
Other liabilities4,0703,0905,7617,1094,0171,965
Other undisclosed current liabilities4,1434,0976,0383,0614,5082,608
Total current liabilities:37,63045,37855,32351,94951,69536,692
Noncurrent Liabilities
Long-term debt and lease obligation96,237197,375130,11396,33636,65537,718
Long-term debt, excluding current maturities96,237197,375130,11396,33629,76229,674
Finance lease, liability      
Liabilities, other than long-term debt3,6773,5284,5835,727312570
Deferred revenue406844101151312570
Operating lease, liability3,2712,6844,4825,5766,8938,044
Other undisclosed noncurrent liabilities  2,695896113721240
Total noncurrent liabilities:99,914203,598135,592102,17637,68838,528
Total liabilities:137,544248,976190,915154,12589,38375,220
Equity
Equity, attributable to parent126,95226,819122,886245,990374,081328,609
Common stock185350484743
Additional paid in capital1,298,1381,116,4471,084,5151,035,4561,000,212822,624
Accumulated other comprehensive income (loss)1724268(564)(184)1
Accumulated deficit(1,171,376)(1,089,723)(961,747)(788,950)(625,994)(494,059)
Total equity:126,95226,819122,886245,990374,081328,609
TOTAL LIABILITIES AND EQUITY:264,496275,795313,801400,115463,464403,829

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues119,476113,689130,376115,375102,60249,935
Cost of revenue
(Cost of Product and Service Sold)		(72,722)(75,125)(101,376)(97,542)(94,994)(62,972)
Gross profit:46,75438,56429,00017,8337,608(13,037)
Operating expenses(113,460)(151,939)(198,770)(178,852)(138,127)(104,430)
Operating loss:(66,706)(113,375)(169,770)(161,019)(130,519)(117,467)
Nonoperating income7,4089,76110,1713,291498526
Interest and debt expense (7,685) (12,675)(4,933)(1,715)(4,458)
Loss from continuing operations before equity method investments, income taxes:(66,983)(103,614)(172,274)(162,661)(131,736)(121,399)
Other undisclosed loss from continuing operations before income taxes(13,952)(23,871)   (93)
Loss from continuing operations before income taxes:(80,935)(127,485)(172,274)(162,661)(131,736)(121,492)
Income tax expense(718)(491)(523)(295)(199) 
Loss from continuing operations:(81,653)(127,976)(172,797)(162,956)(131,935)(121,492)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(131,935)(121,492)
Net loss attributable to parent:(81,653)(127,976)(172,797)(162,956)(131,935)(121,492)
Preferred stock dividends and other adjustments      (362)
Net loss available to common stockholders, diluted:(81,653)(127,976)(172,797)(162,956)(131,935)(121,854)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(81,653)(127,976)(172,797)(162,956)(131,935)(121,492)
Comprehensive loss:(81,653)(127,976)(172,797)(162,956)(131,935)(121,492)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent130(26)632(380)(185)(21)
Comprehensive loss, net of tax, attributable to parent:(81,523)(128,002)(172,165)(163,336)(132,120)(121,513)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: